Skip to main content
Log in

Maintained Bone Density in Young Hypoestrogenized Women with a High BMI: Case Series

  • Case Reports
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Estrogen deficiency and obesity are factors that affect bone mass in a manner that is independent and in opposing directions. Obesity favours higher bone mass and increased bone formation whereas estrogen deficiency leads to significant bone loss in leaner individuals. To report the impact of the competing effects of a hypoestrogenized state and obesity on long-term bone health, we present two cases of young chronically hypoestrogenized females whose bone parameters were assessed with high-resolution peripheral quantitative computed tomography (HR-pQCT) and revealed a bone mineral density and microstructure that did not change despite the long history of a low estrogen state. As evidenced by the outcomes for these patients, the obesity-related effect on bone mass may be dominant when obesity is marked and appears to be highly protective even in the setting of sub-physiologic circulating estrogen. Recognition of this interaction should be considered in decisions around estrogen replacement therapy in such cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Jia J, Zhou H, Zeng X, Feng S (2017) Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. Mol Med Rep [Internet]. [cited 2020 Nov 3], 15(4): 1539–1546. Available from: /pmc/articles/PMC5364970/?report=abstract

  2. Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab [Internet]. [cited 2020 Oct 16], 23(11): 576–581. Available from: /pmc/articles/PMC3424385/?report=abstract

  3. Cauley JA (2015) Estrogen and bone health in men and women. Steroids 99(Part A):11–15

    Article  CAS  Google Scholar 

  4. Podfigurna-Stopa A, Czyzyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K et al (2016) Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest [Internet]. [cited 2020 Oct 15], 39(9): 983–990. Available from: https://link-springer-com.ezproxy.lib.ucalgary.ca/article/https://doi.org/10.1007/s40618-016-0467-z

  5. Adams JE (2013) Advances in bone imaging for osteoporosis. Nat Rev Endocrinol 9(1):28–42

    Article  CAS  Google Scholar 

  6. Nishiyama KK, Shane E (2013) Clinical imaging of bone microarchitecture with HR-pQCT. Curr Osteoporos Rep 11(2):147–155

    Article  Google Scholar 

  7. Evans AL, Paggiosi MA, Eastell R, Walsh JS (2015) Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res [Internet]. [cited 2020 Oct 16], 30(5): 920–928. Available from: http://doi.wiley.com/https://doi.org/10.1002/jbmr.2407

  8. Burt LA, Liang Z, Sajobi TT, Hanley DA, Boyd SK (2016) Sex- and site-specific normative data curves for HR-pQCT. J Bone Miner Res [Internet]. [cited 2020 Dec 9], 31(11): 2041–2047. Available from: http://doi.wiley.com/https://doi.org/10.1002/jbmr.2873

  9. Whittier DE, Burt LA, Hanley DA, Boyd SK (2020) Sex‐ and site‐specific reference data for bone microarchitecture in adults measured using second‐generation HR‐pQCT. J Bone Miner Res [Internet]. [cited 2020 Dec 9], 35(11): 2151–2158. Available from: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/jbmr.4114

  10. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest [Internet]. [cited 2020 Nov 3], 111(8): 1221–1230. Available from: /pmc/articles/PMC152939/?report=abstract

  11. Bord S, Ireland DC, Beavan SR, Compston JE (2003) The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone [Internet]. [cited 2020 Nov 5], 32(2): 136–141. Available from: https://pubmed.ncbi.nlm.nih.gov/12633785/

  12. Szeliga A, Maciejewska-Jeske M, Męczekalski B (2018) Bone health and evaluation of bone mineral density in patients with premature ovarian insufficiency. Prz. Menopauzalny [Internet]. [cited 2020 Oct 15], 17(3): 112–116. Available from: https://doi.org/https://doi.org/10.5114/pm.2018.78552

  13. Uygur D, Sengül Ö, Bayar D, Erdinç S, Batioǧlu S, Mollamahmutoglu L (2005) Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet [Internet]. [cited 2020 Nov 5], 273(1): 17–9. Available from: https://link-springer-com.ezproxy.lib.ucalgary.ca/article/https://doi.org/10.1007/s00404-005-0029-7

  14. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the framingham study. J Bone Miner Res [Internet]. [cited 2020 Nov 4], 8(5): 567–573. Available from: https://asbmr-onlinelibrary-wiley-com.ezproxy.lib.ucalgary.ca/doi/full/https://doi.org/10.1002/jbmr.5650080507

  15. Viljakainen H, Ivaska KK, Paldánius P, Lipsanen-Nyman M, Saukkonen T, Pietiläinen KH et al (2014) Suppressed bone Turnover in obesity: a link to energy metabolism? A case-control study. J Clin Endocrinol Metab [Internet]. [cited 2020 Oct 16], 99(6): 2155–2163. Available from: https://academic.oup.com/jcem/article/99/6/2155/2537832

  16. Savvidis C, Tournis S, Dede AD (2018) Obesity and bone metabolism. Hormones [Internet]. [cited 2020 Oct 16], 17(2): 205–217. Available from: https://doi.org/https://doi.org/10.1007/s42000-018-0018-4

  17. Singhal V, Sanchita S, Malhotra S, Bose A, Flores LPT, Valera R et al (2019) Suboptimal bone microarchitecure in adolescent girls with obesity compared to normal-weight controls and girls with anorexia nervosa. Bone [Internet]. [cited 2021 Apr 7], 122: 246–253. Available from: https://pubmed.ncbi.nlm.nih.gov/30853658/

  18. Perez EA, Serene M, Durling FC, Weilbaecher K (2006) Aromatase inhibitors and bone loss. Oncology [Internet]. [cited 2021 Apr 9], 20(9): 1029–39. Available from: /pmc/articles/PMC2693896/

  19. Leite-Silva P, Bedone A, Pinto-Neto AM, Costa JV, Costa-Paiva L (2009) Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure. Arch Gynecol Obstet [Internet]. [cited 2020 Oct 17], 280(2): 177–181. Available from: https://link-springer-com.ezproxy.lib.ucalgary.ca/article/https://doi.org/10.1007/s00404-008-0881-3

  20. Kim KC, Shin DH, Lee SY, Im JA, Lee DC (2010) Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J [Internet]. [cited 2020 Oct 17], 51(6): 857–863. Available from: /pmc/articles/PMC2995981/?report=abstract

  21. Premaor MO, Pilbrow L, Tonkin C, Parker RA, Compston J (2010) Obesity and fractures in postmenopausal women. J Bone Miner Res 25(2):292–297

    Article  Google Scholar 

  22. Webber L, Anderson RA, Davies M, Janse F, Vermeulen N (2017) HRT for women with premature ovarian insufficiency: a comprehensive review. Hum Reprod Open [Internet]. [cited 2020 Oct 16], 2017(2). Available from: https://pubmed.ncbi.nlm.nih.gov/30895225/

  23. Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ et al (2009) Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension [Internet]. [cited 2020 Nov 4], 53(5): 805–811. Available from: https://www.ahajournals.org/doi/https://doi.org/10.1161/HYPERTENSIONAHA.108.126516

Download references

Funding

No funding was received to assist with the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Anabel Cardenas Rivas or Gregory A. Kline.

Ethics declarations

Disclosure

Anabel Cardenas Rivas, Lauren A Burt, Micheil Innes, Steven K Boyd, Gregory A. Kline have no relevant financial or non-financial interests to disclose.

Human and Animal Rights and Informed Consent

This retrospective case series involving human participants was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. According to the Calgary Health Research and Ethics Board, formal approval is not required for case reports provided the subjects have given written informed consent. Informed, written consent was given by both patients for publication of clinical details and imaging results.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivas, A.C., Burt, L.A., Innes, M. et al. Maintained Bone Density in Young Hypoestrogenized Women with a High BMI: Case Series. Calcif Tissue Int 109, 469–473 (2021). https://doi.org/10.1007/s00223-021-00857-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-021-00857-w

Keywords

Navigation